New Targeted Treatment IMMU-130 Shows Promise in Patients with Metastatic Colon Cancer
CHICAGO (May 18, 2015) — Although various drugs have improved outcomes for metastatic colon cancer patients, researchers continually strive to find new agents to improve treatment. Antibody-drug conjugates are a promising option, due to the fact that they can deliver chemotherapy directly into a targeted cell and destroy tumor cells while keeping healthy ones intact.